Latest News in the pharma Industry

All

FDA approves Vectibix for use in wild-type RAS metastatic colorectal cancer

FDA approves Vectibix for use in wild-type RAS metastatic colorectal cancer

2 Jul 2017

First-and-only fully human monoclonal anti-epidermal growth factor receptor antibody approved by the FDA for this patient population.

Read more 
Gyros Protein Technologies introduces new ADA solution for immunogenicity market

Gyros Protein Technologies introduces new ADA solution for immunogenicity market

2 Jul 2017

Developed to support assay development and validation for detection of anti-drug antibodies.

Read more 
Exscientia enters strategic drug discovery collaboration with GSK

Exscientia enters strategic drug discovery collaboration with GSK

2 Jul 2017

Pre-clinical collaboration focused on up to 10 targets nominated by GSK.

Read more 
Patheon to invest $45 million, expanding capabilities to support continued growth

Patheon to invest $45 million, expanding capabilities to support continued growth

2 Jul 2017

Investments in commercial and development spray drying, and flexible manufacturing solutions.

Read more 
Bioverativ completes acquisition of True North Therapeutics

Bioverativ completes acquisition of True North Therapeutics

29 Jun 2017

Strengthens leadership in rare blood disorders with first-in-class candidate to treat cold agglutinin disease, a chronic autoimmune hemolytic anemia with no approved therapies.

Read more 
First prostate cancer patients treated with Augmenix's SpaceOAR Hydrogel in Israel

First prostate cancer patients treated with Augmenix's SpaceOAR Hydrogel in Israel

29 Jun 2017

The Chaim Sheba Medical Center now offers the hydrogel spacer to reduce side-effects during prostate cancer radiation therapy.

Read more 
Copley Scientific releases upgraded SPU 2000 for reduced inhaler testing variability

Copley Scientific releases upgraded SPU 2000 for reduced inhaler testing variability

29 Jun 2017

Company's modification makes the SPU 2000 a more cost effective laboratory tool.

Read more 
Novartis receives EU approval for first-line use of Zykadia in ALK-positive advanced NSCLC

Novartis receives EU approval for first-line use of Zykadia in ALK-positive advanced NSCLC

29 Jun 2017

In ALK-positive advanced NSCLC patients, Zykadia demonstrated superior median progression-free survival compared with SOC chemotherapy with maintenance.

Read more 
INTERVIEW ON BIOCORP’S CONNECTED MEDICAL DEVICES

INTERVIEW ON BIOCORP’S CONNECTED MEDICAL DEVICES

28 Jun 2017

In this interview, Mr Guillet discusses Biocorp’s existing connected device offering, how it delivers value for the company’s pharmaceutical partners, the development of the accompanying software and data architecture, and how Biocorp has very signific...

Read more 
Researchers develop microneedle patch for flu vaccination

Researchers develop microneedle patch for flu vaccination

28 Jun 2017

The patch can dramatically reduce the cost of vaccination, as self-administration can eliminate the need to have health workers oversee the process.

Read more 
BASF plans significant investment in ibuprofen capacities in Germany and North America

BASF plans significant investment in ibuprofen capacities in Germany and North America

28 Jun 2017

New world-scale ibuprofen production plant in Ludwigshafen; additional capacity expansion of ibuprofen plant in Bishop, Texas.

Read more 
UK availability of Rixathon and Erelzi paves way for NHS savings

UK availability of Rixathon and Erelzi paves way for NHS savings

28 Jun 2017

Two new biosimilar medicines available to treat patients with specific blood cancers and a range of inflammatory condition.

Read more